CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_122922842_122923044 | Zfp105 | 129 | 0.907763 | -0.12 | 3.7e-01 | Click! |
chr9_122923082_122924014 | Zfp105 | 449 | 0.642266 | -0.11 | 4.0e-01 | Click! |
chr9_122924971_122925122 | Zfp105 | 1947 | 0.157235 | 0.07 | 6.0e-01 | Click! |
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_185456264_185456428 | 1.61 |
Gm2061 |
predicted gene 2061 |
778 |
0.45 |
chr18_10028293_10028725 | 1.57 |
Usp14 |
ubiquitin specific peptidase 14 |
1513 |
0.38 |
chr11_64931371_64931975 | 1.52 |
Elac2 |
elaC ribonuclease Z 2 |
47365 |
0.15 |
chr12_32123180_32123577 | 1.32 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
324 |
0.89 |
chr13_45924669_45925312 | 1.21 |
4930453C13Rik |
RIKEN cDNA 4930453C13 gene |
11050 |
0.22 |
chr12_101025986_101026137 | 1.20 |
Ccdc88c |
coiled-coil domain containing 88C |
2848 |
0.16 |
chr15_98377565_98377733 | 1.14 |
Olfr283 |
olfactory receptor 283 |
1548 |
0.24 |
chr1_181839488_181840486 | 1.09 |
Gm26004 |
predicted gene, 26004 |
581 |
0.64 |
chr15_103250315_103251530 | 1.08 |
Nfe2 |
nuclear factor, erythroid derived 2 |
543 |
0.62 |
chr19_31868788_31869365 | 1.05 |
A1cf |
APOBEC1 complementation factor |
295 |
0.93 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 1.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 1.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 1.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 1.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 0.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 0.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 1.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 1.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 1.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 1.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 1.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 1.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 1.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 1.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 1.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 2.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 2.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 1.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 1.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 1.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |